H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure. Census population 542,107. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Fresno clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Fresno storefront.
Wharton's Jelly Allograft Products in Fresno, CA for clinics & physicians. Wharton's jelly allografts rich… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 21.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure. Together those PLACES numbers are why a city of 500k–1M still needs separate PRP and CTP protocols. whartons jelly allograft inventory is national; utilization is JE-local.
National Wharton's Jelly Allograft Products notes (how the product actually works)CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure. Adult obesity in Fresno is 37.5% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 21.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JE / Noridian Healthcare Solutions, sibling states HI, NV. California Department of Public Health is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a Fresno warehouse or a five-star local review. What you get is whartons jelly allograft from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JE, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 12.7% of adults — 0.7 points above the U.S. 12% figure. Obesity is 37.5%; arthritis is 21.2%. That is place-level BRFSS modeling, not a clinic census and not a Fresno trial.
No. Organization schema on this site does not publish a fake aggregateRating. Testimonials on marketing pages are not assigned to Fresno as local reviews.
It is the Census city-proper count — useful as scale for a city of 500k–1M. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
If you operate in California and another MAC state, say it on the first call. JE will not port 1:1. We would rather split utilization than watch a sister clinic copy Fresno tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Fresno, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Fresno is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Fresno — 0.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Fresno. Useful for joint-program math; still needs a diagnosis and privileging.
No Fresno storefront. Joe Bradley is an active practice owner. whartons jelly allograft stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.